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Abstract
It is well established that phospholipase C (PLC) h1 plays a role in the nuclear compartment and is involved in the signalling pathway that
controls the switching of the erythroleukemia cells programming from an undifferentiated to a differentiated state. Constitutive
overexpression of nuclear PLCh1 has been previously shown to inhibit Friend cells differentiation. For further characterization, we
investigated the localization of PLCh1a and PLCh1b in Friend cells by fusing their cDNA to enhanced green fluorescent protein (GFP). To
investigate the potential target of nuclear PLCh1 in Friend differentiation, we studied the expression of p45/NF-E2 transcription factor, which
is an enhancer binding protein for expression of the h-globin gene and the expression of GATA proteins that are important for the survival
and differentiation of erythroid cells. Our data suggest that the overexpression of PLCh1 (both 1a and 1b) only in the nuclear compartment
significantly reduces the expression of p45/NF-E2. The effect observed is attributable to the specific action of nuclear PLCh1 signalling given
that GATA-1 and GATA-3 are not affected at all. Here we show the existence of a unique target, i.e. the transcription factor p45/NF-E2,
whose expression is specifically inhibited by the nuclear signalling evoked by PLCh1 forms. D 2002 Elsevier Science B.V. All rights
reserved.
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1. Introduction
Murine erythroleukemia cells are widely used as a model
of erythroid differentiation and provide a useful system for
studying the mechanism that controls globin gene expres-
sion. These Friend virus-transformed cells can be induced to
differentiate into erythroid cells by the addition of DMSO1 or
other chemical agents. The cells begin to synthesize a variety
of erythroid-specific proteins, including h-globin. The exis-
tence of a signal transduction system in the nucleus, based on
polyphosphoinositide breakdown mediated by specific phos-
pholipase C (PLC), has been widely documented [1-4].
It has been reported previously, by us and others, that the
erythroid differentiation of murine erythroleukemia cells is
associated with a down-regulation of the nuclear PLCh1 [5].
PLCh1 is composed of two subtypes, 150 kDa PLCh1a and
140 kDa PLCh1b [6], which are detectable in both cytosolic
and nuclear fraction even if PLCh1b is located almost
exclusively in the nucleus [7]. In a previous study, which
we conducted to elucidate the functional role of nuclear
PLCh1 in the regulation of growth and differentiation of
Friend erythroleukemia cells, we express PLCh1 in the
nucleus and we have demonstrated that this overexpression
of the PLCh1 was sufficient to block erythroid differentia-
tion of Friend cells induced by DMSO [8].
The program of biochemical and molecular events nec-
essary for the commitment of erythroid cell differentiation is
particularly well characterized in murine Friend erythroleu-
kemia cell line. When exposed to DMSO or other inducers,
Friend cells undergo phenotypic changes that resemble the
final stage of normal erythropoiesis. The most striking
feature is the increased synthesis of globin chains, which
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results primarily from the activation of globin gene tran-
scription. Expression of globin gene is dependent on far-
upstream locus control region [9]. The promoter of globin
genes contains target sites for NF-E2 and GATA transcrip-
tion factors. In Friend erythroleukemia cells, DMSO
increases the activity of NF-E2 that is an obligate hetero-
dimer composed of two different subunits, p45, which is
restricted to hematopoietic cells, and an ubiquitously
expressed p18 [10,11]. p45/NF-E2 contains a basic region
leucin zipper DNA binding domain and it plays a critical
role in erythroid differentiation as an enhancer-binding
protein for expression of h-globin gene. The promoter and
enhancer of globin genes contain also target sites for the
transcription factor GATA-1, a transcription factor belong-
ing to the GATA family, essential for various aspects of the
development of the hematopoietic lineages [12]. Three
members of the GATA family have emerged as important
transcription factors in hematopoietic cells. GATA-1, the
founding member of this family, is expressed at high level in
erythroid cells, mast cells, megakaryocytes, eosinophils and
at a low level in multipotential progenitors [13]. GATA-2 is
expressed in broad distribution among hematopoietic cells,
with particularly prominent expression in early progenitors
[14]. GATA-3, which is expressed in T lymphocytes, is
essential for T-lymphoid cell development [15]. GATA-1
and p45/NF-E2 appear to be the major cell-restricted, DNA-
binding protein that interact directly with the DNA of the
locus control region cores.
Therefore, in order to understand which among the
transcription factors that controls the transcription of globin
gene is the possible target of nuclear PLC signaling activity
in erythroid differentiation, we decided to overexpress, in
the Friend erythroleukemia cells, the PLCh1a, PLCh1b and
a mutant in the COOH-terminal region, M2b, lacking the
ability of localizing at the nucleus.
Our experiments show that when Friend cells are induced
to differentiate along the erythroid lineage, a forced expres-
sion of nuclear PLCh1 blocks specifically the expression of
p45/NF-E2, while GATA family is not affected.
2. Materials and methods
2.1. Construction of expression vectors and transfection
The full-length cDNA for rat PLCh1a [16], the full-length
cDNA for rat PLCh1b [6] and the mutant for nuclear local-
ization sequence, in which by site-directed mutagenesis
lysine residues 1056, 1063 and 1070 in region 2 of the
COOH-terminus were substituted with isoleucine [17], were
cloned into pRc/CMV (Invitrogen) expression vector plas-
mid as described elsewhere [18]. Friend cells were trans-
fected using the following protocol. Briefly, a mixture of 2.5
Ag of plasmid DNA and 10 Al of Transfectam (Promega) was
added to 1105 cells in one well of a six-well plate for 24 h
The transformants were selected by limiting dilution in
medium containing the neomycin analogue G418 at a con-
centration of 500 ng/ml. Clones were harvested and
expanded separately in the presence of G418. The full cDNA
of PLCh1a PLCh1b and PLCh1M2b with EcoRI sites in the
5V and 3V termini was produced by PCR. The PCR products
for the PLCh1s was digest with EcoRI and subcloned in the
EcoRI site of the pEGFP vector (Clontech Labs, Palo Alto,
CA), preserving the reading frame.
For experiments with green fluorescent protein (GFP)-
construct, transiently transfected Friend cells were plated
onto glass coverslip 48 h before observation. Then, the
coverslips were mounted on a heated stage with the medium
temperature kept at 37 jC. The fluorescence of GFP in
living cells was examined in a Zeiss Axiophot fluorescence
microscope.
2.2. Cell culture
Murine erythroleukemia cells (Friend cells, clone 707)
were grown in RPMI 1640 supplemented with 10% foetal
calf serum. Erythroid differentiation was induced by addi-
tion of either 1.5% DMSO (v/v) for the indicated times.
2.3. Isolation of nuclei
A hypotonic shock combined with nonionic detergent,
essentially described by Martelli et al. [19], has been used.
In addition to 0.5 mM phenylmethylsulfonyl fluoride, 10
mM h-mercaptoethanol, 1 mM ethylene glycol-bis(ami-
noethyl ether) tetraacetic acid, 10 Ag/ml leupeptin, 0.3 AM
aprotinin, 15 Ag/ml calpain I inhibitor and 7.5 Ag/ml calpain
II inhibitor were also added to the buffers. Nuclear purity
was assessed by detection of h-tubulin as described in Ref.
[20], and only nuclei showing in Western blot a complete
absence of h-tubulin were used in the reported experiments.
2.4. Preparation of cytoplasmic fraction
The cytoplasmic fraction was obtained by homogenizing
cells with 20 strokes in a Dounce homogeniser 10 mM Tris–
Cl, pH 7.8–2 mM MgCl2 plus protease inhibitors as above
and then pelleting the nuclei at 400 g. This procedure
allows the recovery of pure cytoplasmic fraction and avoid
the risk of contamination by nuclear debris that are present in
the crude supernatant from nuclear purification.
2.5. Preparation of nuclear extracts
Nuclear extracts were prepared by resuspending the cells
in 400 Al of swelling buffer (10 mM Hepes pH 7.9, 1.5 mM
MgCl2, 10 mM KCl), followed by incubation on ice for 10
min. Next, the lysates were vortexed for 10 s before centri-
fugation for 1 min at 14,000 rpm at 4 jC. The pelleted nuclei
were resuspended in 50 Al of lysis buffer (20 mM Hepes pH
7.9, 25% glycerol, 420 mM NaCl, 1.5 mM MgCl2, 0.2 mM
EDTA) and left on ice for 20 min with occasional mixing.
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Subsequently, the lysates were centrifuged at 14,000 rpm for
10 min at 4 jC, and the supernatant was stored at  70 jC.
All buffers were supplemented with 0.5 mM DTT and 0.2
mM PMSF.
2.6. Immunochemical analysis
Immunoblot analysis of 50 Ag of nuclear and cytoplas-
mic fraction were resolved by SDS-PAGE and blotted to
nitrocellulose membrane for subsequent immunodetection
with the same antibody, followed by detection using ECL
(Amersham). For Western blot analysis, proteins from
nuclear extract (20 Ag) were separated on a polyacrylamide
0.1% SDS gel and transferred on to nitrocellulose paper.
The following antibodies were used: polyclonal antibodies
to p45/NF-E2, monoclonal antibodies to GATA-1, GATA-2
and GATA-3 from Santa Cruz Biotechnology; polyclonal
antibody to PLCh1 (a and b) from Transduction Laboratory.
3. Results
We sought to compare the distribution of PLCh1a and
PLCh1b in Friend cells in the presence and absence of
DMSO. Fig. 1 shows that PLCh1a is especially distributed
in the cytoplasm while PLCh1b is, above all, localized in the
nucleus. Moreover, both of them are down regulated when
Friend erythroleukemia cells, treated with DMSO, differ-
entiate. To investigate the role of PLCh1 on erythroid
differentiation, we stably expressed the wild types and the
mutant for the nuclear localization sequence in Friend
erythroleukemia cells. The Western blot analysis of the
clones overexpressing the PLCh1a, PLCh1b and of the
mutant PLChM2b, show that the overexpression of PLCh1a
a gives rise to an equal distribution in both nucleus and
cytoplasm. PLCh1b is essentially nuclear. The overexpres-
sion of the mutant M2b, in which lysine residues 1056, 1063
and 1070 were substituted with isoleucine, show that the
M2b mutant has lost the capacity for nuclear localization
(Fig. 2). In addition, we have to mention that the over-
expression of PLCh1 in the nucleus determines a consistent
increase in PLC activity and a resistance to DMSO treatment,
in that beta-globin expression is almost completely abolished
[8]. A further system for monitoring protein localization uses
GFP as a molecular tag. Therefore, we investigated the
subcellular localization of PLCh1 subtypes by fusing them
to GFP. cDNAs coding for PLCh1a, PLCh1b and PLChM2b
were amplified with PCR and introduced into the pEGFP-N1
expression vector, which generated PLCh1s-EGFP fusion
proteins when transfected into mammalian cells. After the
cDNA constructs have been verified by sequencing, the
GFP-PLCh1a, b and M2b were transiently overexpressed
in Friend cells. As shown in Fig. 3, GFP-PLCh1b localizes
almost exclusively in the cell nucleus. GFP-PLCh1a accu-
mulates in the cytoplasm, as well as in the nucleus. On the
contrary the GFP-PLCh1M2b mutant distributes throughout
specifically the cytoplasm, being completely absent in the
nucleus. Therefore, the GFP labeling is in complete agree-
ment with immunochemical data about subcellular local-
ization of PLCh1 forms.
Fig. 1. Intracellular distribution of PLCh1 phenotype during Friend cells
differentiation. Immunochemical analysis with anti-PLCh1 (a and b). Sixty
micrograms of protein loaded for each lane. cu, cytoplasm from uninduced
cells; ci, cytoplasm from induced cells; nu, nuclei from uninduced cells; ni,
nuclei from induced cells. The intensity of the band of the cytoplasmic
fraction of PLCh1a is stronger than that of the nuclear fraction, while the
intensity of the band of the nuclear fraction of PLCh1b is stronger than that
of the cytoplasmic fraction, which is almost completely absent.
Fig. 2. Analysis of PLCh1 phenotype in stable transfectants during Friend
cells differentiation. nu, ni, cu, ci: as in the Fig. 1. Immunoblot analysis of
60 Ag of nuclear lysate of the stable transfectants and immunoblot analysis
of 60 Ag of cytoplasmic lysate of the stable transfectants. 1a, cells
transfected with PLCh1a; 1b, cells transfected with PLCh1b; M2b, cells
transfected with PLCh1M2b. The images show both the overexpressed
proteins and the endogenous one. The Western blot of stable transfectants
reported here are representative of five other clones, which behaved in an
identical fashion.
Fig. 3. Intracellular localization of GFP-tagged PLCh1 subtypes and
PLCh1M2b mutant proteins in living cells. Friend cells growing in medium
containing 10% calf serum were transiently transfected with the GFP-
tagged constructs of PLCh1a, PLCh1b and PLCh1M2b mutant, respec-
tively. At 48 h post-transfection, cells were viewed with a Zeiss Axiophot
fluorescence microscope and photographed. The picture is representative of
five separate transfections and all transfected cells showed the same pattern
in each experimental condition.
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Given that nuclear PLCh1 is involved in the signaling
machinery that controls erythroid differentiation of Friend
cells in vitro, we tried to find out the possible targets of
nuclear PLCh1 signaling. Therefore, taking advantage of
stable transfectants, with different subcellular localization of
PLCh1, we decided to assess the levels of p45/NF-E2 and
GATA proteins by immunoblot analysis. NF-E2 plays a
critical role in erythroid differentiation as an enhancer
binding-protein for the expression of the h-globin gene
and is a differentiative marker in Friend cells differentiation
even if the commitment to hemopoietic pathways is not
achieved by a single factor, but rather by combinatorial
mechanism that take place within 48 h of induction with
differentiative agent. Fig. 4 shows the level of expression of
the hematopoietic factor p45/NF-E2 in the stable trans-
fectants and in wild type cells cultured for different times
(48–72 h) in the presence or absence of DMSO. The
overexpression of PLCh1a and PLCh1b induces a clear lack
of increase in p45/NF-E2 level in the cells treated with
DMSO, whereas the overexpression of the mutant
PLCh1M2b did not affect the level of the hematopoietic
factor as compared to wild type cells. The time course of
p45/NF-E2 expression indicates that this factor, which is
absent in undifferentiated erythroid cells [8], is expressed at
48 h after treatment with the inducer and peaks at 72 h when
h-globin initiates to be expressed [8].To establish whether
p45/NF-E2 was a specific target of nuclear PLCh1, GATA-
1, 2 and 3 expression was also examined in Friend cells
induced to differentiate with DMSO since these GATA
family transcription factors are important regulators of gene
expression in hematopoietic lineages. Fig. 5 shows that
GATA-1 and GATA-3 increases up to 72 h in the presence
of DMSO. Their expression is the same in wild type cells as
well as in clones overexpressing PLCh1 forms in the
nucleus and in the mutant for the nuclear localization
sequence, suggesting that GATA-1 and GATA-3 are not
affected by the nuclear localization of PLCh1. Fig. 5 also
shows that GATA-2 is not expressed in Friend cells, in
agreement with the finding that this transcription factor is
highly expressed only in early erythroid cells, which is not
the case for Friend cells we dealt with since they do not
belong to an early stage of the erythroid lineage [14].
4. Discussion
Friend murine erythroleukemia cells provide a useful
system for studying the mechanism that controls both
erythroid differentiation and globin gene expression. The
aim of this study was to clarify whether the nuclear
localization of the PLCh1 forms is connected to specific
targets during differentiation of Friend erythroleukemia
cells. It has been demonstrated by our group that PLCh1
is down regulated when Friend cells treated with DMSO
differentiate and synthesize h-globin [20]. Furthermore, it
has also been demonstrated that overexpression of a
specific, nuclear-localized, PLCh1 isoform is sufficient to
maintain the undifferentiated state of Friend cells induced
by DMSO [8], possibly due to a continuous stimulation of
the cell cycle. Furthermore, we have recently demonstrated
that Friend erythroleukemia cells overexpressing PLCh1
isoforms that localize to the nucleus (PLCh1a and b) can
grow in the absence of serum because cyclin D3 is also
overexpressed, and the active complex phosphorylates
pRb, then activating the E2F transcription factor [21].
Fig. 4. Enforced expression of the nuclear PLCh1 is sufficient to block p45/
NF-E2. Cells were induced to differentiate for 48 and 72 h with DMSO.
Immunoblot analysis of 50 Ag of nuclear extracts of wt and stably
transfected cells. wt, wild type cells; 1a, cells transfected with PLCh1a; 1b,
cells transfected with PLCh1b; M2b, cells tranfected with PLCh1M2b. U,
uninduced cells; I, induced cells. The densitometric analysis of the blots
indicates that at 48 h, there is a 10-fold increase of the intensity of p45/NF-
E2 in induced wt cells, while in PLCh1a and b clones, the increase is less
than 2-fold. At 72 h, the increase in wt cells is more than 20-fold while in
PLCh1a and b clones, the increase is only 2-fold. The Western blot of stable
transfectants reported here are representative of five other clones, which
behaved exactly as the ones in the figure.
Fig. 5. Effect of PLCh1 subtypes overexpression on GATA-1, GATA-2 and
GATA-3 transcription factors levels. Cells were induced to differentiate for
48 and 72 h with DMSO. Immunoblot analysis of 50 Ag of nuclear extracts
of wt and stably transfected cells. wt, wild type cells; 1a, cells transfected
with PLCb1a; 1b, cells transfected with PLCh1b; M2b, cells tranfected
with PLCh1M2b. U, uninduced cells; I, induced cells. The Western blot of
stable transfectants reported here are representative of five other clones,
which behaved in an identical fashion.
I. Faenza et al. / Biochimica et Biophysica Acta 1589 (2002) 305–310308
Previous work showed that nuclear localization depends on
a cluster of lysine residues in the COOH-terminal domain
[17]. Therefore, we have used the mutant PLCh1M2b,
lacking the ability of localizing at the nucleus, to find out
the possible nuclear target of PLCh1 during erythroid
differentiation. In this work, we have compared the
expression and localization of PLCh1 forms in control
cells with cells undergoing differentiation that has been
induced by DMSO. To do this, we have made use of the
GFP technology, which provides unprecedented opportu-
nities to study the enzymes involved in nuclear lipid
signalling pathway in living cells [22] and circumvents
problems such as contamination by residues of the plasma
membrane, antibody cross reaction or fixation and inad-
equate antibody penetration in the case of fluorescent
signal in immunocytochemical investigations. Therefore,
to facilitate the detection of transfected cells, the PLCh
subtypes and the mutant for the nuclear localization
sequence PLChM2b were fused to enhanced GFP. The
experiments described here demonstrated that the expres-
sion of transcription factor p45/NF-E2, a prerequisite in the
erythroid differentiation of Friend cells, is modulated by
nuclear PLCh1, as the overexpression of the nuclear
subtypes, instead of the mutant PLChM2b, abolishes
almost completely DMSO-induced p45/NF-E2 expression.
It is likely that, in these cells, the overexpression of the
mutant for the nuclear localization sequence, PLCh1M2b,
prevents nuclear PLCh1a and b from translocating to the
nuclear compartment. This result assigns to nuclear PLCh1
a role as a negative regulator of erythroid differentiation
and its nuclear signalling might have a relevance for the
pathogenesis of cancer since Friend cells with high levels
of nuclear wild type PLCh1 actively synthesizes DNA
even after having been cultured for 3–4 days in the
presence of DMSO [8]. We found that expression of
GATA-1 was not reduced in Friend cells after nuclear
PLCh1 overexpression, suggesting that this nuclear signal
has indeed a specific target, which is p45/NF-E2, while
GATA-1 expression is not affected at all by nuclear
PLCh1. This implies that there are two different signalling
pathways that control the expression levels of these two
transcription factors. In fact, a recent report by Bavelloni et
al. [23] demonstrates that the binding of the transcription
factors GATA-1 to its DNA-binding site is modulated by
PI3-Kinase pathway, as wortmannin abolishes almost com-
pletely DMSO-induced GATA-1 binding to DNA. On the
other hand, it should be remembered that Martelli et al.
[24] have shown that nuclear PLCh1 strictly depends on its
phosphorylation, which is mediated through the MAPK
pathway. Furthermore, we have recently demonstrated that
there is a cross-talk between the MAPK cascade and a
PLC signalling pathway, that is that ERK evoked phos-
phorylation of PLCh1 at serine 982 [25]. Therefore, our
results are in agreement with the recent finding that DNA
binding and transactivation activity of p45/NF-E2 are
regulated by serine/threonine phosphorylation such as a
MAPK signaling cascade [11]. It has recently been
described that loss of p45/NF-E2 expression is required
for the establishment of permanent erythroleukemic cell in
culture. The absence of p45/NF-E2 in erythroleukemic
cells promotes tumor growth by accelerating the rate of
cellular proliferation. This transcription factor has a direct
role in the regulation of globin gene expression in eryth-
roid cells, possibly because it functions as a tumor sup-
pressor gene in Friend virus-induced erythroleukemias
[26]. The data presented here clearly demonstrated that
specific subcellular localization of the two subtypes is
responsible for differences in their biological function.
Upon DMSO treatment, the two different subtypes PLCh1a
a and b, when localized in the nucleus, have the same
nuclear target, which is the transcription factor p45/NF-E2.
This target is highly specific since other transcription
factors involved in erythroid differentiation of Friend cells,
such as members of GATA family, do not respond to
nuclear PLCh1 signaling. Therefore, we could assign a
specific role for this signalling pathway in Friend cells
programming from a differentiative to a proliferative state.
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